'Toxic erythema' and eosinophilia associated with tocilizumab therapy in a COVID-19 patient.
J Eur Acad Dermatol Venereol
; 34(8): e368-e370, 2020 Aug.
Article
in English
| MEDLINE | ID: covidwho-209922
Semantic information from SemMedBD (by NLM)
1. Tocilizumab therapy TREATS COVID-19
2. COVID-19 PROCESS_OF Patients
3. Tocilizumab therapy AFFECTS Eosinophilia
4. Tocilizumab therapy AFFECTS Toxic erythema
5. Tocilizumab therapy TREATS Patients
6. Tocilizumab therapy TREATS COVID-19
7. COVID-19 PROCESS_OF Patients
8. Tocilizumab therapy AFFECTS Eosinophilia
9. Tocilizumab therapy AFFECTS Toxic erythema
10. Tocilizumab therapy TREATS Patients
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Eosinophilia
/
Erythema
/
Antibodies, Monoclonal, Humanized
/
Betacoronavirus
Type of study:
Case report
Topics:
Long Covid
Limits:
Aged
/
Humans
/
Male
Language:
English
Journal:
J Eur Acad Dermatol Venereol
Journal subject:
Dermatology
/
Sexually Transmitted Diseases
Year:
2020
Document Type:
Article
Affiliation country:
Jdv.16620
Similar
MEDLINE
...
LILACS
LIS